M
Mark D. Hurwitz
Researcher at Thomas Jefferson University
Publications - 121
Citations - 3239
Mark D. Hurwitz is an academic researcher from Thomas Jefferson University. The author has contributed to research in topics: Prostate cancer & Radiation therapy. The author has an hindex of 30, co-authored 119 publications receiving 2764 citations. Previous affiliations of Mark D. Hurwitz include Dana Corporation & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results
Mark D. Hurwitz,Pejman Ghanouni,Sergey Kanaev,Dmitri Iozeffi,David Gianfelice,Fiona M. Fennessy,Abraham Kuten,Joshua E. Meyer,Suzanne LeBlang,Ann Roberts,Junsung Choi,James Larner,Alessandro Napoli,Vladimir Turkevich,Yael Inbar,Clare M. Tempany,Raphael Pfeffer +16 more
TL;DR: This multicenter phase III trial demonstrated that MRgFUS is a safe and effective, noninvasive treatment for alleviating pain resulting from bone metastases in patients that have failed standard treatments.
Journal ArticleDOI
Biochemical Outcome Following External Beam Radiation Therapy With or Without Androgen Suppression Therapy for Clinically Localized Prostate Cancer
Anthony V. D'Amico,Delray Schultz,Marian Loffredo,Raymond Dugal,Mark D. Hurwitz,Irving D. Kaplan,Clair J. Beard,Andrew A. Renshaw,Philip W. Kantoff +8 more
TL;DR: The data suggest a significant benefit in 5-year PSA outcomes for men with clinically localized prostate cancer in intermediate- and high-risk groups treated with RT plus AST vs those treating with RT alone.
Journal ArticleDOI
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
Veda N. Giri,Karen E. Knudsen,William Kevin Kelly,Heather H. Cheng,Kathleen A. Cooney,Michael S. Cookson,William L. Dahut,Scott Weissman,Howard R. Soule,Daniel P. Petrylak,Adam P. Dicker,Saud H. AlDubayan,Amanda E. Toland,Colin C. Pritchard,Curtis A. Pettaway,Mary B. Daly,James L. Mohler,J. Kellogg Parsons,Peter R. Carroll,Robert Pilarski,Amie Blanco,Ashley H. Woodson,Alanna Kulchak Rahm,Mary-Ellen Taplin,Thomas J. Polascik,Brian T. Helfand,Colette Hyatt,Alicia K. Morgans,Felix Y. Feng,Michael Russell Mullane,Jacqueline Powers,Raoul S. Concepcion,Daniel W. Lin,Richard C. Wender,James Ryan Mark,Anthony J. Costello,Arthur L. Burnett,Oliver Sartor,William B. Isaacs,Jianfeng Xu,Jeffrey N. Weitzel,Gerald L. Andriole,Himisha Beltran,Alberto Briganti,Lindsey Byrne,Anne Calvaresi,Thenappan Chandrasekar,David Y.T. Chen,Robert B. Den,Albert Dobi,E. David Crawford,James A. Eastham,Scott E. Eggener,Matthew L. Freedman,Marc B. Garnick,Patrick T. Gomella,Nathan Handley,Mark D. Hurwitz,Joseph K Izes,R. Jeffrey Karnes,Costas D. Lallas,Lucia R. Languino,Stacy Loeb,Ana Maria Lopez,Kevin R. Loughlin,Grace L. Lu-Yao,S. Bruce Malkowicz,Mark Mann,Patrick Mille,Martin Miner,Todd M. Morgan,Jose Moreno,Lorelei A. Mucci,Ronald E. Myers,Sarah M. Nielsen,Brock O'Neil,Wayne H. Pinover,Peter A. Pinto,Wendy Poage,Ganesh V. Raj,Timothy R. Rebbeck,Charles J. Ryan,Howard M. Sandler,Matthew J. Schiewer,E. Michael D. Scott,Brittany M. Szymaniak,William Tester,Edouard J. Trabulsi,Neha Vapiwala,Evan Y. Yu,Charnita Zeigler-Johnson,Leonard G. Gomella +91 more
TL;DR: This multidisciplinary, consensus-driven PCA genetic implementation framework provides novel guidance to clinicians and patients tailored to the precision era and includes optimal pretest informed consent, post-test discussion, cascade testing, and technology-based approaches.
Journal ArticleDOI
Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017
Veda N. Giri,Karen E. Knudsen,William Kevin Kelly,Wassim Abida,Gerald L. Andriole,Chris H. Bangma,Justin E. Bekelman,Mitchell C. Benson,Amie Blanco,Arthur L. Burnett,William J. Catalona,Kathleen A. Cooney,Matthew R. Cooperberg,David Crawford,Robert B. Den,Adam P. Dicker,Scott E. Eggener,Neil Fleshner,Matthew L. Freedman,Freddie C. Hamdy,Jean H. Hoffman-Censits,Mark D. Hurwitz,Colette Hyatt,William B. Isaacs,William B. Isaacs,Christopher J. Kane,Philip W. Kantoff,R. Jeffrey Karnes,Lawrence Karsh,Eric A. Klein,Daniel W. Lin,Kevin R. Loughlin,Grace L. Lu-Yao,S. Bruce Malkowicz,Mark Mann,James Ryan Mark,Peter A. McCue,Martin Miner,Todd M. Morgan,Judd W. Moul,Ronald E. Myers,Sarah M. Nielsen,Elias Obeid,Christian P. Pavlovich,Stephen C. Peiper,David F. Penson,Daniel P. Petrylak,Daniel P. Petrylak,Curtis A. Pettaway,Robert Pilarski,Peter A. Pinto,Wendy Poage,Ganesh V. Raj,Timothy R. Rebbeck,Mark E. Robson,Matt T. Rosenberg,Howard M. Sandler,Oliver Sartor,Edward M. Schaeffer,Gordon F. Schwartz,Mark S. Shahin,Neal D. Shore,Brian Shuch,Howard R. Soule,Scott A. Tomlins,Edouard J. Trabulsi,Robert G. Uzzo,Robert G. Uzzo,Donald J. Vander Griend,Patrick C. Walsh,Carol J. Weil,Richard C. Wender,Leonard G. Gomella +72 more
TL;DR: This is the first comprehensive, multidisciplinary consensus statement to address a genetic evaluation framework for inherited PCA in the multigene testing era and should focus on developing a working definition of familial PCA for clinical genetic testing.